3.1
Amantadine (Lysovir, Symmetrel, Alliance Pharmaceuticals) acts against influenza A virus by blocking viral replication. It has a UK marketing authorisation for the treatment of people who have signs and symptoms of infection caused by influenza A virus. The summary of product characteristics (SPC) states that treatment should be started as early as possible, and within 48 hours of symptom onset. The recommended dosage of amantadine is 100 mg daily for 4 to 5 days. Amantadine is administered orally as syrup (Symmetrel) or 100-mg capsules (Lysovir) for the treatment of influenza.